Expression change of SPN in human microglia was reported in Alzheimer's disease [33]; Specific carbonyl level of CORO1A was reduced during the treatment to reduce Amyloid β-peptide levels in mouse model [34]. This evidence concerns the gene SPN and Alzheimer disease.